Integrative molecular concept modeling of prostate cancer progression

被引:712
|
作者
Tomlins, Scott A.
Mehra, Rohit
Rhodes, Daniel R.
Cao, Xuhong
Wang, Lei
Dhanasekaran, Saravana M.
Kalyana-Sundaram, Shanker
Wei, John T.
Rubin, Mark A.
Pienta, Kenneth J.
Shah, Rajal B.
Chinnaiyan, Arul M. [1 ]
机构
[1] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Sch Med, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA
[3] Univ Michigan, Sch Med, Bioinformat Program, Ann Arbor, MI 48109 USA
[4] Univ Michigan, Sch Med, Dept Urol, Ann Arbor, MI 48109 USA
[5] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA
[6] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA
[7] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA
关键词
D O I
10.1038/ng1935
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Despite efforts to profile prostate cancer, the genetic alterations and biological processes that correlate with the observed histological progression are unclear. Using laser-capture microdissection to isolate 101 cell populations, we have profiled prostate cancer progression from benign epithelium to metastatic disease. By analyzing expression signatures in the context of over 14,000 'molecular concepts', or sets of biologically connected genes, we generated an integrative model of progression. Molecular concepts that demarcate critical transitions in progression include protein biosynthesis, E26 transformation-specific (ETS) family transcriptional targets, androgen signaling and cell proliferation. Of note, relative to low-grade prostate cancer (Gleason pattern 3), high-grade cancer (Gleason pattern 4) shows an attenuated androgen signaling signature, similar to metastatic prostate cancer, which may reflect dedifferentiation and explain the clinical association of grade with prognosis. Taken together, these data show that analyzing gene expression signatures in the context of a compendium of molecular concepts is useful in understanding cancer biology.
引用
收藏
页码:41 / 51
页数:11
相关论文
共 50 条
  • [31] Molecular markers of progression in tramp and human prostate cancer.
    Gingrich, JR
    Wheeler, TM
    Greenberg, NM
    [J]. JOURNAL OF UROLOGY, 1998, 159 (05): : 4 - 4
  • [32] Microsatellite allelotyping identifies molecular progression markers in prostate cancer
    Von Knobloch, R
    Konrad, L
    Barth, JP
    Brandt, H
    Wille, S
    Heidenreich, A
    Hofmann, R
    [J]. JOURNAL OF UROLOGY, 2003, 169 (04): : 57 - 57
  • [33] Molecular sampling of prostate cancer: a dilemma for predicting disease progression
    Sboner, Andrea
    Demichelis, Francesca
    Calza, Stefano
    Pawitan, Yudi
    Setlur, Sunita R.
    Hoshida, Yujin
    Perner, Sven
    Adami, Hans-Olov
    Fall, Katja
    Mucci, Lorelei A.
    Kantoff, Philip W.
    Stampfer, Meir
    Andersson, Swen-Olof
    Varenhorst, Eberhard
    Johansson, Jan-Erik
    Gerstein, Mark B.
    Golub, Todd R.
    Rubin, Mark A.
    Andren, Ove
    [J]. BMC MEDICAL GENOMICS, 2010, 3
  • [34] Prostate cancer: molecular biology of early progression to androgen independence
    Sadar, MD
    Hussain, M
    Bruchovsky, N
    [J]. ENDOCRINE-RELATED CANCER, 1999, 6 (04) : 487 - 502
  • [35] Molecular mechanisms of castration-resistant prostate cancer progression
    Dutt, Smitha S.
    Gao, Allen C.
    [J]. FUTURE ONCOLOGY, 2009, 5 (09) : 1403 - 1413
  • [36] Molecular Alterations during Progression of Prostate Cancer to Androgen Independence
    Saraon, Punit
    Jarvi, Keith
    Diamandis, Eleftherios P.
    [J]. CLINICAL CHEMISTRY, 2011, 57 (10) : 1366 - 1375
  • [37] Identification of Molecular Markers Associated with Prostate Cancer Subtypes: An Integrative Bioinformatics Approach
    Granata, Ilaria
    Barboro, Paola
    [J]. BIOMOLECULES, 2024, 14 (01)
  • [38] Mathematical modeling of prostate cancer progression in response to androgen ablation therapy
    Jain, Harsh Vardhan
    Clinton, Steven K.
    Bhinder, Arvinder
    Friedman, Avner
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2011, 108 (49) : 19701 - 19706
  • [39] Introduction to "Molecular drivers of prostate cancer development, progression, and resistance to therapy"
    Barbieri, Christopher E.
    [J]. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2018, 36 (08) : 367 - 367
  • [40] Molecular Links Between Angiogenesis and Neuroendocrine Phenotypes in Prostate Cancer Progression
    Wang, Zheng
    Zhao, Yicheng
    An, Zhiqiang
    Li, Wenliang
    [J]. FRONTIERS IN ONCOLOGY, 2020, 9